International Society for Cell & Gene Therapy Expanded Access Working Group position paper: key considerations to support equitable and ethical expanded access to investigational cell- and gene-based interventions
Open Access
- 7 February 2025
- journal article
- Published by Elsevier in Cytotherapy
- Vol. 27 (6) , 671-677
Abstract
No abstract availableKeywords
Funding Information
- Institut des Sciences du Cerveau de Toulouse
This publication has 36 references indexed in Scilit:
- Perspectives of Academic Oncologists About Offering Expanded Access to Investigational DrugsJAMA Network Open, 2022
- The ‘false hope’ argument in discussions on expanded access to investigational drugs: a critical assessmentMedicine, Health Care and Philosophy, 2022
- International Country-Level Trends, Factors, and Disparities in Compassionate Use Access to Unlicensed Products for Patients With Serious Medical ConditionsJAMA Health Forum, 2022
- Implementation of 21st Century Cures Act Expanded Access Policies RequirementsClinical Pharmacology & Therapeutics, 2021
- Oncology Expanded Access and FDA's Project FacilitateThe Oncologist, 2021
- The Critical Role of Medical Institutions in Expanding Access to Investigational InterventionsHastings Center Report, 2019
- Medical Marketing in the United States, 1997-2016JAMA, 2019
- Promoting Patient Interests in Implementing the Federal Right to Try ActJAMA, 2018
- Academic DetailingJAMA, 2017
- The Ethical Challenges of Compassionate UseJAMA, 2016